Source link : https://tech365.info/apple-appeals-us-ban-on-apple-watch-blood-oxygen-characteristic/
Apple has requested a U.S. federal appeals courtroom to overturn an import ban on Apple Watch fashions with blood oxygen monitoring capabilities, arguing that the choice was based mostly on a patent dispute involving an undeveloped competing product, Reuters experiences.
On Monday, attorneys for Apple appeared earlier than a three-judge panel on the U.S. Courtroom of Appeals for the Federal Circuit to contest a 2023 ruling by the U.S. Worldwide Commerce Fee (ITC) that blocked imports of the Apple Watch Sequence 9 and Apple Watch Extremely 2 in 2023 as a consequence of alleged patent infringement. The ban stemmed from a grievance filed by Masimo, a medical know-how agency based mostly in California, which accused Apple of violating its patents associated to pulse oximetry — the measurement of blood oxygen saturation by non-invasive sensors.
Apple’s authorized counsel this week argued that the ITC’s ruling was unjustified as a result of, on the time Masimo filed its grievance in 2021, the corporate had not but introduced a competing product to market. Masimo’s first smartwatch, the W1, which included blood oxygen monitoring, was not launched till 2022 — two years after Apple launched the characteristic with the Apple Watch Sequence 6.
Apple maintains that Masimo’s gadget was not market-ready when the corporate filed its grievance, and that the authorized customary mustn’t allow hypothetical merchandise to justify commerce restrictions. The choice had wrongly…
—-
Author : tech365
Publish date : 2025-07-08 06:27:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8